Zentalis Pharmaceuticals (ZNTL) Goodwill (2019 - 2024)

Zentalis Pharmaceuticals' Goodwill history runs 6 years deep, the most recent figure standing at $3.7 million for Q3 2024.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $3.7 million in Q3 2024; TTM through Sep 2024 was $3.7 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $3.7 million, changed 0.0% from the prior year.
• Goodwill steadied at $3.7 million in Q3 2024 per ZNTL's latest filing, from $3.7 million in the prior quarter.
• Across five years, Goodwill topped out at $3.7 million in Q1 2020 and bottomed at $3.7 million in Q1 2020.
• The 5-year median for Goodwill is $3.7 million (2020), against an average of $3.7 million.
• Biggest YoY gain for Goodwill was 0.0% in 2020; the steepest drop was 0.0% in 2020.
• Year by year, Goodwill stood at $3.7 million in 2020, then changed by 0.0% to $3.7 million in 2021, then changed by 0.0% to $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then changed by 0.0% to $3.7 million in 2024.
• Per Business Quant, the three latest ZNTL Goodwill figures stand at $3.7 million (Q3 2024), $3.7 million (Q2 2024), and $3.7 million (Q1 2024).